Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Credit Suisse hires...

    Credit Suisse hires Rapkin for healthcare investment banking

    Written by Ruby Khatun Khatun Published On 2017-06-07T09:39:11+05:30  |  Updated On 7 Jun 2017 9:39 AM IST
    Credit Suisse hires Rapkin for healthcare investment banking

    Credit Suisse Group AG has hired Cory Rapkin as vice chairman in the healthcare group of its investment banking and capital markets division, according to an internal memo seen by Reuters and confirmed by a spokesman from Credit Suisse


    Rapkin, who was previously with JPMorgan Chase & Co, will work alongside David Kostel and Steve Schwartz to grow Credit Suisse's franchise in healthcare services, the memo said. He will be based in New York and will start in early September.


    Last year, two of Credit Suisse's healthcare managing directors, Stuart Smith and Michael Muntner, left for boutique investment bank Centerview Partners.


    Credit Suisse has been rapidly scaling up its healthcare franchise in recent years, making five senior level hires since 2015.


    Its healthcare team has been on some of the biggest deals in the sector so far this year, at a time when healthcare M&A has slowed considerably due to political uncertainty.


    Some of the deals Credit Suisse has advised on include in Ventiv Health's $7.4 billion merger with INC Research Holdings Inc, Johnson & Johnson's $30 billion acquisition of Actelion, and Fresenius SE & Co's $4.3 billion acquisition of Akorn Inc.


    Rapkin spent more than a decade building up JP Morgan's healthcare services coverage, working with clients including UnitedHealth Group Inc, HCA Healthcare Inc and DaVita Inc.


    (Reporting by Carl O'Donnell in New York; Editing by Andrew Hay)

    ActelionAkorn IncCory RapkinCredit SuisseDavid KostelFresenius SEhealthcare investment bankinghireJPMorgan ChaseMichael MuntnerSteve SchwartzStuart Smith
    Source : REUTERS

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok